Chargement en cours...
Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor
Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms defined by the presence of cells with secretory granules and the potential to produce and release high levels of vasoactive peptides into the circulation, leading to severe flushing and diarrhea, which may adversely affect quality of...
Enregistré dans:
| Publié dans: | Case Rep Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger AG
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4649750/ https://ncbi.nlm.nih.gov/pubmed/26600780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000441775 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|